CAS 827319-43-7

Formule : C31H39F2NO6

InChI : InChI=1S/C31H39F2NO6/c1-16-12-18-19-14-21(32)20-13-17(35)8-9-28(20,6)30(19,33)22(36)15-29(18,7)31(16,25(38)39-11-10-34)40-24(37)23-26(2,3)27(23,4)5/h8-9,13,16,18-19,21-23,36H,11-12,14-15H2,1-7H3/t16-,18+,19+,21+,22+,28+,29+,30+,31+/m1/s1

Code InChI : WUBKGTSFJSEIEM-NSHBDUGJSA-N

SMILES : C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)OCC#N)OC(=O)C5C(C5(C)C)(C)C)C)O)F)C)F

GW-870086

CAS : 827319-43-7

GW-870086 is an effective anti-inflammatory agent.

Formule : C₃₁H₃₉F₂NO₆

Degré de pureté : 99.86%

Couleur et forme : Solid

Masse moléculaire : 559.6413

Ref: TM-T15451

GW-870086

CAS : 827319-43-7

GW-870086

Formule : C₃₁H₃₉F₂NO₆

Degré de pureté : ≥98%

Masse moléculaire : 559.64

Ref: 54-BUP09796

GW-870086

CAS : 827319-43-7

Formule : C₃₁H₃₉F₂NO₆

Degré de pureté : 98%

Masse moléculaire : 559.6413

Ref: IN-DA01JWQ9

GW-870086

CAS : 827319-43-7

GW-870086 is a synthetic small molecule compound classified as a selective glucocorticoid receptor agonist. It is derived from structured pharmaceutical research aimed at developing targeted therapies with minimal systemic side effects. This compound selectively binds to glucocorticoid receptors, modulating the transcription of glucocorticoid-responsive genes while attenuating inflammation and immune responses.

Formule : C₃₁H₃₉F₂NO₆

Degré de pureté : Min. 95%

Masse moléculaire : 559.65 g/mol

Ref: 3D-CIB31943